Consul the latest articles online for free and stay up to date on recent findings and best practices by subscribing to the emails alerts.
Watch the recording
This webinar was based on the presentation and discussion of two difficult clinical cases of AS patients. The first case was a patient with Low-Gradient symptomatic AS with an Aortic Area < 1 cm2. The discussion focused on the necessity to check for errors in measurement and correlation to body surface of the area. It was also discussed the need for further investigations such as an exercise test (not indicated in symptomatic but only in asymptomatic patients) In this case it is better to do a Dobutamine ECHO. Moreover were discussed the not utility of a TEE, while the measurement of calcium score with CT, and the measurement of LVOT diameter are important. The second case was a severe AS in an asymptomatic ‘lower’ risk patient with previous chest Radiotherapy for Hodgkin disease. The speakers also discussed the presence of symptoms and the related mortality and morbidity: prognosis is improved by treatment only when symptoms are present. Also if the higher the gradient, the higher the related event rates, an intervention in asymptomatic subjects has unproven results. If aortic calcification is present, TAVI is the better choice for intervention but mitral calcification may complicate TAVI with a poor outcome. However TAVI is to be preferred over surgical replacement (SAVR) in case of previous irradiation and thoracotomies, porcelain aorta, not relevant mitral regurgitation, patient wish.
This webinar was broadcasted after the publication of the new version of the Valvular Heart Diseases (VHDs) Guidelines in August. Three clinical cases were discussed. The first case was a 40 year old pregnant female with Bicuspid Valve AS. Apparently the AS got worse; but in the presence of a condition of reversible high flow, which may elevate the valvular gradient, it is necessary to re-evaluate the AS after delivery. In severe AS, intervention should be guaranteed in presence of a low EF, symptoms or symptom development during an exercise test, and also marked BNP elevation and pulmonary hypertension development. In patients at low risk the SAVR is still the choice. The second case highlighted the essential role of the heart team for the management. The patient studied was very old, and presented a very high risk due to CAD, peripheral VD, PM for II BAV, COPD. The intervention choice was a trans-apical approach TAVI (he was not suitable for SAVR and not for trans-femoral TAVI approach). This case was very useful to discuss the issues in favour of the indication for TAVI vs SAVR. The third case was a very complex patient with a previous replacement of the aortic root and ascending aorta with severe Aortic Regurgitation, very low EF (20%), severe MR. In this very difficult and risky situation, an operation using a SAVR, and a mitral valve repair may be the solution.
The mission of the Council for Cardiology Practice has been modified to: "Improve the standard of care in clinical cardiology practice of office based general cardiologists".
After long discussions, adjustments and modifications, the Council Nucleus has proposed modifications regarding its mission and audience. Finally, the nucleus has reached a new definition.
The Council for Cardiology Practice was created in 2000 to gather cardiologists working in private practice. Across the years, the Council welcomed new countries with different healthcare systems. Among them, colleagues working in an out of hospital setting, which was not ‘fully private’, with some kind of reimbursement directly or indirectly paid by the National Heart Service, became preponderant. The qualifying aspects of the cardiologists in practice are:
So the Council decided to modify slightly but essentially its mission insisting less on the ‘private’ aspect and more on the profession.
The Council proposed these changes to the ESC Board and after many prolific discussions and corrections; we came up with a new definition of our mission statement.
So we, as general cardiologists, should ‘not know everything of something’, but ‘know something of everything’.
This will be our commitment for the next years.
As many other ESC Constituent Bodies, the Council for Cardiology Practice is now launching a simplified Direct Membership. Thus, general cardiologists who are not members of one of the national associations represented in the Council can become members.
The procedure to apply requires only a few minutes.
See here the benefits of your direct membership!
Be one of the first to join the Council for Cardiology Practice, your Council about general cardiology!
Yes, we did it! In recent years, the European Society of Cardiology has relied more and more on social media to share knowledge and stimulate discussion. The Council for Cardiology Practice is now following this example and according to ESC rules, has opened a LinkedIn group for its members.
This platform is an opportunity to share your knowledge; to engage with the leaders of the Council for Cardiology Practice; to actively participate in conversations and spark new ideas and debates; create a long-lasting network with like-minded people.
We invite you to add value through your knowledge and to keep the conversations dynamic and fruitful so that the entire network can benefit from this unique sharing experience.
The goals of the CCP LinkedIn group are:
Please note that the access to the LinkedIn group is a member benefit. Thus, you will have to log in to your My ESC Account to join the group.
Join the Council for Cardiology Practice now to share your knowledge and extend your network!
Discover these special sessions on General Cardiology focussing on:
Watch the presentations
Access all ESC Congress resources
An article about the Council for Cardiology Practice (CCP)
Read this CardioPulse article about CCP.
Eur Heart J (2016) 37(19): 1485-1492 DOI: http://dx.doi.org/10.1093/eurheartj/ehw143
The Systolic Blood Pressure Intervention Trial (SPRINT) was designed to test whether a treatment program aimed at reducing systolic blood pressure (SBP) to a lower goal (120mmHg) than currently recommended (140mmHg) could reduce cardiovascular disease (CVD) risk.
Dr. Marc Ferrini from the Council for Cardiology Practice has contributed this review of the Sprint Trial.
Here are the most recent ESC Guidelines.
Access the full list of ESC Guidelines
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved